Prevalence of Diagnosed and Undiagnosed Diabetes in a Rural Community: A Home-Based Screening

Diabetes has a global prevalence in developed countries and rapidly flexing its roots in middle-and low-income countries. According to the World Health Organization, it is a major cause of kidney collapse, heart problems, and lower limb amputation. Diabetes mellitus is a metabolic disorder showing an uncontrolled increase in blood glucose levels. To date, no permanent cure has been developed for the complete restoration of impaired glucose haemostasis. With the use of therapeutic agents and nontherapeutic agents, glucose levels can be kept in control for a very long time. The foremost goal of all current ongoing treatments is to control high blood glucose levels, reduction in elevated lipid levels, and delay in the progression of diabetes-related complications. Various therapeutics agents are developed in recent decades, which shown very promising results in the management of diabetes mellitus. These agents prescribed after reviewing the clinical symptoms and situation of an individual patient. This review compiles noteworthy information related to clinically approved medicaments for diabetes mellitus. Review emphasis on categorization, mechanism of action, noted adverse effects along with the physiological responses of used medicines to treat diabetes mellitus.

Section: Non-therapeutic Methodsmentioning

confidence: 99%

Systematic Review on Medicaments Used in Management of Diabetes Mellitus

Jamwal¹

2020

“…Diabetes is one of the world's biggest death risk, with a dramatic spike in the age span in developed countries [52]. The international federation for diabetes records 415 million diabetes mellitus patients around the world [53].…”

Section: Management Of Diabetes During This Pandemicmentioning

confidence: 99%

Management of Diabetes With Covid-19: A Review

Kumari

Kaur

Hussain

2020

Objective: As of now, the world is struggling with a serious pandemic of disease 2019 Coronavirus (COVID-19), which was emerged from Wuhan in China, originated by the novel coronavirus 2019 (SARS-CoV-2). COVID-19 is a viral illness, which is occurring on a large scale in every nation of the globe. Symptoms of coronavirus mainly include fever, fatigue, cough, headache, pneumonia and in severe condition, there is respiratory distress. The deadly virus alarmed the world to be on high alert as the number of rising cases and the death toll rising as the day passes. Methods: We have searched for articles of preference and interest systematically in sources like Google Scholar, PubMed, and other outlets. Results: Management in the case of diabetes is really necessary to decrease their mortality. Certain management parameters need to be followed to take care of patients suffering from both diseases. Conclusion: In this review, we highlighted the role of different medicines like chloroquine, lopinavir, and hydroxychloroquine for the remedy of this pandemic. We also discussed the chest Computed tomography functions and Real-time polymerase chain reaction for the screening of the outbreak. The center of attention of this review majorly on the care of diabetes throughout the time of the COVID-19 epidemic.

“…In this regard, according to the Indian diabetes study report of The Indian Council of Medical Research (ICMR), the vulnerable prediabetic population is estimated to be around 77.2 million currently. Which is more than the current diabetic population in India [4]. Hence, the Prediabetic population has a potential risk of transforming itself into overt diabetes in 5 y, if not identified, and interviewed with necessary lifestyle modifications at once [5].…”

Section: Introductionmentioning

confidence: 99%

Identification and Assessment of Prediabetes-a Rural Indian Study (A Correlative Study Between Questionnaire and Biochemical Analysis)

Venkatesan

Susila

Suthanthiran

et al. 2020

Objective: To identify and prevent the vulnerable prediabetic population becoming diabetic patients in the future using the Indian Diabetic Risk Score (IDRS) and to evaluate the performance of the IDRS questionnaire for detecting prediabetes and predicting the risk of Type 2 Diabetes Mellitus in Chidambaram rural Indian population. Methods: A cross-sectional descriptive study was carried out among patients attending a master health check-up of RMMCH hospital located at Chidambaram. The IDRS was calculated by using four simple measures of age, family history of diabetes, physical activity, and waist measurement. The relevant blood test, like Fasting plasma glucose (FBS), Glycated hemoglobin (HbA1C) test, were observed for identifying prediabetes. Subjects were classified as Normoglycemic, prediabetics, and diabetics based on the questionnaire and diagnostic criteria of the Indian Council of Medical Research (ICMR) guidelines. Results: In the study, sensitivity and specificity of IDRS score were found to be 84.21% and 63.4% respectively for detecting prediabetes in community with the positive predictive value of 51.6% and negative predictive value of 89.6% and prevalence of prediabetes in the Chidambaram rural population is 31.6% among the 60 participants. Conclusion: The Indian diabetic risk score questionnaire designed by Madras diabetic research federation is a useful screening tool to identify unknown type 2 diabetes mellitus. The questionnaire is a reliable, valuable, and easy to use screening tool which can be used in a primary care setup.